Clinical Trial

Outcomes After Unified Versus Standard GDM Diagnosis

Study acronym: UPDATE-GDM
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2024 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Gestational diabetes mellitus (GDM) is a condition that can affect pregnant women during pregnancy and may cause complications for the mother and the baby. Therefore, early and accurate detection is necessary to provide the woman and the baby with better health outcomes. Currently, the most commonly used criteria to detect GDM is the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criterion. However, there is a suggestion that it results in over-diagnosis of GDM, and newer methods of diagnosis have been proposed. One such proposal is to have more than a binary outcome of assessment of dysglycemia in pregnancy. The investigator group created this criterion known as the National Priorities Research Program (NPRP) criterion. This clinical trial compares the IADPSG to the NPRP criteria in pregnant women in Qatar to determine if this newer method mitigates overdiagnosis and more accurately identifies women at risk of complications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-03.
Trial Details
NCT Number NCT06401629
Lead Sponsor Qatar University
Collaborators: Hamad Medical Corporation
Conditions Gestational Diabetes, Diagnosis, Pregnancy
Enrollment 2,650 participants
Start Date 2025-01-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-08